Bank of America
MIRA icon

Bank of America’s MIRA Pharmaceuticals MIRA Stock Holding History

Bank of America’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-261
Closed -$395 – 6436
2025
Q4 		$395 Buy
261
+121
+86% +$178 ﹤0.01% 6594
2025
Q3 		$190 Buy
140
+21
+18% +$30 ﹤0.01% 7744
2025
Q2 		$144 Sell
119
-9,984
-99% -$11.5K ﹤0.01% 7907
2025
Q1 		$9.9K Buy
10,103
+4
+0% +$5 ﹤0.01% 7113
2024
Q4 		$11.5K Buy
10,099
+10,011
+11,376% +$13.1K ﹤0.01% 6945
2024
Q3 		$114 Buy
+88
New +$140 ﹤0.01% 7695

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Bank of America's MIRA Position: Q1 2026 in Review

Bank of America sold out of MIRA Pharmaceuticals (MIRA) in Q1 2026, closing a stake of 261 shares — an estimated $395 sold.

Bank of America first reported a position in MIRA in Q3 2024 and held it in 6 quarters. The position peaked at $11.5K in Q4 2024. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Bank of America reported no remaining MIRA Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 261 MIRA Pharmaceuticals shares in Q1 2026, an estimated $395.
  • Bank of America first reported a position in MIRA Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Bank of America's MIRA Pharmaceuticals position peaked at $11.5K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.